| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |